Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
03/02/2023 | ENANTA PHARMACEUTICALS INC | ENTA | Grant | Stock Option (right to buy) | 10.8k | $47.72 | $515.4k | | 03/02/2023 |
01/20/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 4.4k | $0.00 | $0 | | 01/20/2023 |
01/20/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Non Qualified Stock Option (right to buy) | 7.5k | $45.66 | $343.4k | | 01/20/2023 |
08/12/2022 | Mirati Therapeutics, Inc. | MRTX | Exercise | Non Qualified Stock Option (right to buy) | 10k | $27.00 | $270k | | 08/12/2022 |
08/12/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 4.9k | $85.96 | $420.6k | | 08/12/2022 |
08/12/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 5.1k | $85.04 | $434.3k | | 08/12/2022 |
03/21/2022 | ENANTA PHARMACEUTICALS INC | ENTA | Sale | Common Stock | 2.7k | $66.70 | $178.5k | | 03/21/2022 |
03/21/2022 | ENANTA PHARMACEUTICALS INC | ENTA | Sale | Common Stock | 307 | $67.23 | $20.6k | | 03/21/2022 |
03/21/2022 | ENANTA PHARMACEUTICALS INC | ENTA | Sale | Common Stock | 2.2k | $68.66 | $151.7k | | 03/21/2022 |
03/21/2022 | ENANTA PHARMACEUTICALS INC | ENTA | Sale | Common Stock | 807 | $69.52 | $56.1k | | 03/21/2022 |
03/21/2022 | ENANTA PHARMACEUTICALS INC | ENTA | Exercise | Stock Option (Right to Buy) | 6k | $25.58 | $153.5k | | 03/21/2022 |
03/03/2022 | ENANTA PHARMACEUTICALS INC | ENTA | Grant | Stock Option (right to buy) | 7.5k | $68.22 | $511.6k | | 03/03/2022 |
01/14/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 2.5k | $0.00 | $0 | | 01/14/2022 |
01/14/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Non Qualified Stock Option (right to buy) | 3.7k | $124.31 | $458.5k | | 01/14/2022 |
04/05/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 2k | $176.70 | $347.7k | | 04/05/2021 |
04/05/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 282 | $180.00 | $50.8k | | 04/05/2021 |
04/05/2021 | Mirati Therapeutics, Inc. | MRTX | Exercise | Non Qualified Stock Option (right to buy) | 2.2k | $6.78 | $15.3k | | 04/05/2021 |
03/02/2021 | ENANTA PHARMACEUTICALS INC | ENTA | Grant | Stock Option (right to buy) | 7.5k | $49.92 | $374.4k | | 03/02/2021 |
02/02/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 1.7k | $190.50 | $329.9k | | 02/02/2021 |
02/02/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 300 | $192.32 | $57.7k | | 02/02/2021 |
02/02/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 218 | $194.38 | $42.4k | | 02/02/2021 |
02/02/2021 | Mirati Therapeutics, Inc. | MRTX | Exercise | Non Qualified Stock Option (right to buy) | 2.2k | $6.78 | $15.3k | | 02/02/2021 |
01/15/2021 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 1.5k | $0.00 | $0 | | 01/15/2021 |
01/15/2021 | Mirati Therapeutics, Inc. | MRTX | Grant | Non Qualified Stock Option (right to buy) | 2.2k | $214.47 | $462.2k | | 01/15/2021 |
12/14/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 257 | $246.27 | $63.3k | | 12/14/2020 |
12/14/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 710 | $247.63 | $175.8k | | 12/14/2020 |
12/14/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 357 | $248.28 | $88.6k | | 12/14/2020 |
12/14/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 1 | $248.96 | $249 | | 12/14/2020 |
12/14/2020 | Mirati Therapeutics, Inc. | MRTX | Exercise | Non Qualified Stock Option (right to buy) | 2.2k | $6.78 | $15.3k | | 12/14/2020 |
12/14/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 589 | $244.97 | $144.3k | | 12/14/2020 |
12/14/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 287 | $244.05 | $70k | | 12/14/2020 |
12/14/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 49 | $240.93 | $11.8k | | 12/14/2020 |
08/11/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 1.3k | $125.78 | $163.5k | | 08/11/2020 |
08/11/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 740 | $126.71 | $93.8k | | 08/11/2020 |
08/11/2020 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 110 | $127.58 | $14k | | 08/11/2020 |
|